frequently asked questions
Who is eligible for Spravato?
SPRAVATO® may be suitable for adults with major depressive disorder, particularly those experiencing treatment-resistant depression who haven’t responded to at least two different antidepressants. This innovative treatment, which includes esketamine, is also approved for patients dealing with depression and suicidal thoughts. SPRAVATO® is a potential option for individuals who are diagnosed with treatment-resistant depression, are not currently pregnant or nursing, and have no history of substance misuse, as evaluated by Cohen Psychiatric specialists, to ensure overall mental wellness.
Are there any side effects?
Yes, SPRAVATO® (esketamine) can cause side effects such as dizziness, nausea, drowsiness, and a temporary rise in blood pressure. Some patients, particularly those seeking help for treatment-resistant depression at Cohen Psychiatric, may also experience dissociation or a feeling of being disconnected from reality. These effects are usually short-lived and are monitored closely during the required two-hour observation period after each treatment, ensuring the patient's mental wellness.
Can I use my insurance?
At Cohen Psychiatric, we understand that SPRAVATO® (esketamine) is often covered by insurance. Our dedicated care coordinators will assist you in verifying your benefits and managing all necessary paperwork, including prior authorizations and financial assistance, to support your journey toward mental wellness and effectively treating treatment-resistant depression.
Accepted Insurances
